Legal Representation
Attorney
Michele K. Robichaux
USPTO Deadlines
Next Deadline
1806 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241210)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 17, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 17, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 17, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 10, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 10, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 21, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 6, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 3, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Feb 1, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Feb 1, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Nov 8, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 8, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 8, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 28, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 27, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 27, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 24, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 24, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 24, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 19, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 19, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 19, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 3, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Apr 3, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jan 5, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 17, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
A full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use in the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders for use in connection with humans
First Use Anywhere:
Nov 19, 2019
First Use in Commerce:
Nov 19, 2019
Class 044
Providing healthcare and medical information; Providing information in the fields of Oncology, Immunology, and Critical Care
First Use Anywhere:
Nov 19, 2019
First Use in Commerce:
Nov 19, 2019
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"